How does the metabolism of tumour cells differ from that of normal cells.
Level 5 - mechanism / opinion, no new human data
Narrative review of tumor cell metabolic pathways and mechanism-based reasoning without original human data
PubMed 24079832 · doi:10.1042/BSR20130066
What was done
This narrative review synthesized concepts in cancer metabolism, contrasting historical views of mitochondrial dysfunction (the Warburg effect) with evidence regarding mitochondrial viability and respiration. It addressed interconnected pathways such as glutaminolysis and evaluated metabolic inhibition strategies, presenting a case study on the alkylating agent 3-bromopyruvate (3BP) targeting glycolytic enzymes.
What was found
The abstract reports no quantitative values or statistical comparisons. It qualitatively notes that tumor cells display enhanced glycolysis in the presence of oxygen alongside active anabolic pathways for macromolecule synthesis. It also reports that tumor mitochondria remain viable, actively respiring, and essential for tumorigenesis, metastasis, and glutaminolysis, providing viable targets for metabolite analogues.
Why it matters
It clarifies that cancer cells rely on both glycolytic flux and functional mitochondrial respiration rather than purely defective mitochondria, framing these integrated biochemical pathways as therapeutic targets.
Limits
The abstract contains no original experimental data, quantitative outcomes, or systematic literature search methodology. Statements are limited to broad mechanistic concepts and descriptive review observations.
Cited by
- contradicts All major cancers utilize fermentation driven by mitochondrial dysfunction to sustain uncontrolled tumor growth.